Ben Abdallah H, Bech R, Fogh K, et al. - In patients with pyoderma gangrenosum (PG), undiagnosed comorbidities could impact the health and quality of life of patients and ultimately result in death.

• This study included 1604 patients with PG and 16,039 controls to investigate if PG patients had comorbidities and a higher risk of death (mortality) compared to people without PG (controls) in Denmark.

• PG patients were found to have comorbidities that were previously known about, but other comorbidities were also identified in this population.

• PG patients exhibited about three times greater likelihood of death relative to those without PG.